Monomeric and dimeric amidinate complexes of magnesium.

Treatment of anhydrous magnesium bromide with 2 equiv of (1,3-di-tert-butylacetamidinato)lithium, (1,3-di-tert-butylbenzamidinato)lithium, (1,3-diisopropylacetamidinato)lithium, or (1-tert-butyl-3-ethylacetamidinato)lithium (prepared in situ from the corresponding carbodiimide and alkyllithium) in diethyl ether at ambient temperature afforded bis(N,N'-di-tert-butylacetamidinato)magnesium (81%), bis(N,N'-di-tert-butylbenzamidinato)magnesium (82%), bis[bis(N,N'-diisopropylacetamidinato)magnesium] (70%), or bis[bis(1-tert-butyl-3-ethylacetamidinato)magnesium] (93%), respectively, as colorless crystalline solids. These complexes were characterized by spectral and analytical data and by single-crystal X-ray crystallography for bis(N,N'-di-tert-butylbenzamidinato)magnesium, bis[bis(N,N'-diisopropylacetamidinato)magnesium], and bis[bis(1-tert-butyl-3-ethylacetamidinato)magnesium]. In the solid-state structure, bis[bis(1-tert-butyl-3-ethylacetamidinato)magnesium] was found to contain mu,eta(2):eta(1)-amidinato ligands. Bis[bis(N,N'-diisopropylacetamidinato)magnesium] exists in a monomer-dimer equilibrium in toluene-d(8) between -20 and +60 degrees C. A van't Hoff analysis of this equilibrium afforded DeltaH degrees = -14.7 +/- 0.2 kcal/mol, DeltaS degrees = -44.9 +/- 0.2 cal/(mol.K), and DeltaG degrees (298 K) = -1.32 +/- 0.2 kcal/mol. The potential application of the new compounds in the chemical vapor deposition of magnesium-doped group 13 compound semiconductor films is discussed.

Early transition metal complexes containing 1,2,4-triazolato and tetrazolato ligands: synthesis, structure, and molecular orbital studies.

Several early transition metal complexes bearing 1,2,4-triazolato and tetrazolato ligands have been prepared by reaction of the pyrazolato complexes Ti(tBu(2)pz)(4-x)Cl(x) (tBu(2)pz = 3,5-di-tert-butylpyrazolato; x = 1, 2) and M(tBu(2)pz)(5-x)Cl(x) (M = Nb, Ta: x = 2, 3) with the sodium or potassium salts derived from 1,2,4-triazoles and tetrazoles. The X-ray structure analysis of Ti(tBu(2)pz)(2)(Me(2)C(2)N(3))(2) shows eta(2)-coordination of the 1,2,4-triazolato ligands, while in Ti(tBu(2)pz)(3)(C(2)H(2)N(3)) and Nb(tBu(2)pz)(3)(Me(2)C(2)N(3))(2) the analogous groups are joined in a eta(1)-fashion in the solid-state structure. Solution NMR studies at different temperatures suggest transition states involving eta(2)-1,2,4-triazolato ligands for the complexes containing eta(1)-1,2,4-triazolato ligands in the solid state. X-ray crystal structures of analogous tetrazolato complexes Ti(tBu(2)pz)(3)(PhCN(4)) and Nb(tBu(2)pz)(3)(PhCN(4))(2) show eta(1)-coordination of the 2-nitrogen atoms of the tetrazolato ligands. Molecular orbital calculations have been carried out on several model titanium complexes and provide detailed insight into the bonding between early transition metal centers and 1,2,4-triazolato and tetrazolato ligands. The eta(2)-coordination mode of 1,2,4-triazolato and tetrazolato ligands is predicted to be more stable than the eta(1)-coordination mode by 13.8-5.2 kcal/mol.

Direct evidence for a geometrically constrained "entatic state" effect on copper(II/I) electron-transfer kinetics as manifested in metastable intermediates.

The absolute magnitude of an "entatic" (constrained) state effect has never been quantitatively demonstrated. In the current study, we have examined the electron-transfer kinetics for five closely related copper(II/I) complexes formed with all possible diastereomers of [14]aneS(4) (1,4,8,11-tetrathiacyclotetradecane) in which both ethylene bridges have been replaced by cis- or trans-1,2-cyclohexane. The crystal structures of all five Cu(II) complexes and a representative Cu(I) complex have been established by X-ray diffraction. For each complex, the cross-reaction rate constants have been determined with six different oxidants and reductants in aqueous solution at 25 degrees C, mu = 0.10 M. The value of the electron self-exchange rate constant (k(11)) has then been calculated from each cross reaction rate constant using the Marcus cross relation. All five Cu(II/I) systems show evidence of a dual-pathway square scheme mechanism for which the two individual k(11) values have been evaluated. In combination with similar values previously determined for the parent complex, Cu(II/I)([14]aneS(4)), and corresponding complexes with the two related monocyclohexanediyl derivatives, we now have evaluated a total of 16 self-exchange rate constants which span nearly 6 orders of magnitude for these 8 closely related Cu(II/I) systems. Application of the stability constants for the formation of the corresponding 16 metastable intermediates--as previously determined by rapid-scan cyclic voltammetry--makes it possible to calculate the specific electron self-exchange rate constants representing the reaction of each of the strained intermediate species exchanging electrons with their stable redox partners--the first time that calculations of this type have been possible. All but three of these 16 specific self-exchange rate constants fall within--or very close to--the range of 10(5)-10(6) M(-1) s(-1), values which are characteristic of the most labile Cu(II/I) systems previously reported, including the blue copper proteins. The results of the current investigation provide the first unequivocal demonstration of the efficacy of the entatic state concept as applied to Cu(II/I) systems.

Electron/atom transfer in halo-bridged homobimetallic complexes. structure and donor-acceptor properties of face-to-face dicopper complexes with teraazamacrocyclic ligands.

The syntheses and donor-acceptor properties of some novel, halo-bridged dicopper(II) complexes of alpha,alpha'-bis(5,7-dimethyl-1,4,8,11-tetraazacyclotetradecane-6-yl)-o-xylene are reported. These complexes were characterized by their magnetic and electrochemical behavior, X-ray structure analysis, FAB mass spectroscopy, and electronic spectra. The bromo-bridged complex crystallized in the tetragonal system, space group P4(3)2(1)2, with a = 12.6584(5) A, c = 28.6483 (14) A, Z = 4, R = 0.071, and Rw = 0.147. The chloro-bridged complex crystallized in the monoclinic system, space group C2/c, with a = 32.749(2) A, b = 18.8915(9) A, c = 26.022(2) A, beta =114.831 degrees, Z = 12, R = 0.080, and Rw = 0.132. Both molecules have C2 symmetry. The two copper(II) ions are axially bridged by a bromine or a chlorine, and the two macrocycles are bridged by an o-xylene group. Each complex displays a cofacial ring arrangement. The Cu-X distance (where X = Cl, Br) is shorter than the sum of van der Waals radii of Cu and X. The phenyl ring is approximately orthogonal to the Cu-X-Cu axis. The nonhalo-bridged complex has a significant affinity for halides (Kf approximately 10(4) M(-1)). The chloride-bridged complex had barely resolved differential pulse polarographic waves (DeltaE1/2 approximately 28 mV), while the bromide-bridged complex exhibited two CV waves in the 1.0-1.5 V range (DeltaE1/2 = 0.24 V). All the Cu(II)/Cu(I) couples were irreversible with a cathodic peak at about - 0.9 V. The magnetic susceptibility results below 20 K follow Curie-Weiss behavior, indicating that the magnetic interaction between the two Cu centers is weakly antiferromagnetic with J < or = -1 cm(-1) for all three complexes. A bridging-ligand-mediated superexchange model is used to treat the magnetic and electron-transfer coupling in the Cu(II)(X-)Cu(II) complexes. A single set of perturbation theory parameters is consistent with the magnetic and electrochemical observations on the chloride-bridged complex and the magnetic properties of the bromide-bridged complex. The electrochemical behavior of the latter suggests a relatively low-energy, high-spin configuration for the Cu(III)(Br-)Cu(II) complex. The analysis attributes the weak Cu(II)/Cu(II) coupling to the orthogonality of the donor and acceptor orbitals to the bridging axis. It is inferred that bridging halide-mediated metal-metal dsigma/psigma coupling significantly alters the chemical properties of the bimetallic complexes only when the donor and acceptor orbitals are coaxial with the bridging ligand. In such a limit, the coupling takes the form of a three-center bonding contribution.

Effect of conformational constraints on gated electron-transfer kinetics. 3. Copper(II/I) complexes with cis- and trans-cyclopentanediyl-1,4,8,11-tetrathiacyclotetradecane.

Previous kinetic and electrochemical studies of copper complexes with macrocyclic tetrathiaethers-such as 1,4,8,11-tetrathiacyclotetradecane ([14]aneS4)-have indicated that electron transfer and the accompanying conformational change occur sequentially to give rise to a dual-pathway mechanism. Under appropriate conditions, the conformational change itself may become rate-limiting, a condition known as "gated" electron transfer. We have recently hypothesized that the controlling conformational change involves inversion of two donor atoms, which suggests that "gated" behavior should be affected by appropriate steric constraints. In the current work, two derivatives of [14]aneS4 have been synthesized in which one of the ethylene bridges has been replaced by either cis- or trans-1,2-cyclopentane. The resulting copper systems have been characterized in terms of their Cu(II/I)L potentials, the stabilities of their oxidized and reduced complexes, and their crystal structures. The electron self-exchange rate constants have been determined both by NMR line-broadening and by kinetic measurements of their rates of reduction and oxidation with six or seven counter reagents. All studies have been carried out at 25 degrees C, mu = 0.10 M (NaClO4 and/or Cu(ClO4)2), in aqueous solution. Both Cu(II/I) systems show evidence of a dual-pathway mechanism, and the electron self-exchange rate constants representative of both mechanistic pathways have been determined. The first-order rate constant for gated behavior has also been resolved for the Cu(I)(trans-cyclopentane-[14]aneS4) complex, but only a limiting value can be established for the corresponding cis-cyclopentane system. The rate constants for both systems investigated in this work are compared to values previously determined for the Cu(II/I) systems with the parent [14]aneS4 macrocycle and its derivatives involving phenylene and cis- or trans-cyclohexane substituents. The results are discussed in terms of the influence of the fused rings on the probable conformational changes accompanying the electron-transfer process.

Formation and dissociation kinetics and crystal structures of nickel(II)-macrocyclic tetrathiaether complexes in acetonitrile. Comparison to nickel(II)-macrocyclic tetramines.

Complex formation and dissociation rate constants have been independently determined for solvated nickel(II) ion reacting with eight macrocyclic tetrathiaether ligands and one acyclic analogue in acetonitrile at 25 degrees C, mu = 0.15 M. The macrocyclic ligands include 1,4,8,11-tetrathiacyclotetradecane ([14]aneS4) and seven derivatives in which one or both ethylene bridges have been substituted by cis- or trans-1,2-cyclohexane, while the acyclic ligand is 2,5,9,12-tetrathiatridecane (Me2-2,3,2-S4). In contrast to similar complex formation kinetic studies on Ni(II) reacting with corresponding macrocyclic tetramines in acetonitrile and N,N-dimethylformamide (DMF), the kinetics of complex formation with the macrocyclic tetrathiaethers show no evidence of slow conformational changes following the initial coordination process. The differing behavior is ascribed to the fact that such conformational changes require donor atom inversion, which is readily accommodated by thiaether sulfurs but requires abstraction of a hydrogen from a nitrogen (to form a temporary amide). The latter process is not facilitated in solvents of low protophilicity. The rate-determining step in the formation reactions appears to be at the point of first-bond formation for the acyclic tetrathiaether but shifts to the point of chelate ring closure (i.e., second-bond formation) for the macrocyclic tetrathiaether complexes. The formation rate constants for Ni(II) with the macrocyclic tetrathiaethers parallel those previously obtained for Cu(II) reacting with the same ligands in 80% methanol-20% water (w/w). By contrast, the Ni(II) dissociation rate constants show significant variations from the trends in the Cu(II) behavior. Crystal structures are reported for the Ni(II) complexes formed with all five dicyclohexanediyl-substituted macrocyclic tetrathiaethers. All but one are low-spin species.

Synthesis and characterization of calcium complexes containing eta 2-pyrazolato ligands.

Treatment of calcium bromide with 3,5-di-tert-butylpyrazolatopotassium (2 equiv) in tetrahydrofuran afforded Ca(tBu2pz)2(THF)2 (69%). The reaction of this compound with pyridine (3 equiv), tetramethylethylenediamine (TMEDA, 1 equiv), N,N,N',N',N"-pentamethyldiethylenetriamine (PMDETA, 1 equiv), triglyme (1 equiv), and tetraglyme (1 equiv) yielded Ca(tBu2pz)2(py)3 (51%), Ca(tBu2pz)2(TMEDA) (74%), Ca(tBu2pz)2(PMDETA) (50%), Ca(tBu2pz)2(triglyme) (73%), and Ca(tBu2pz)2(tetraglyme) (57%), respectively. Treatment of the tetrahydrofuran adduct of Ca(Me2pz)2, generated in situ, with PMDETA (1 equiv), triglyme (1 equiv), and tetraglyme (1 equiv) afforded Ca(Me2pz)2(PMDETA) (65%), Ca(Me2pz)2(triglyme) (54%), and Ca(Me2pz)2(tetraglyme) (40%), respectively. The X-ray crystal structures of Ca(tBu2pz)2(py)3, Ca(tBu2pz)2(TMEDA), Ca(tBu2pz)2(PMDETA), Ca(tBu2pz)2(triglyme), and Ca(Me2pz)2(PMDETA) revealed six-, seven-, or eight-coordinate calcium centers with eta 2-pyrazolato ligands. Ca(tBu2pz)2(triglyme) sublimes at 160 degrees C (0.1 mmHg). The potential utility of these complexes as source compounds for chemical vapor deposition processes is discussed.

99mTc(L-L)3+ complexes containing ether analogs of DMPE.

Novel 99mTc(L-L)3+ complexes have been investigated for potential use in myocardial perfusion imaging. Bidentate chelators have been prepared that are based on substituent analogs of 1,2-bis(dimethylphosphino)ethane, onto which alkyl ether groups have been incorporated. The new ligands are: (1) MMPE, 1,2-bis(methyl methoxyethyl phosphino)ethane, (2) MIBPE, 1,2-bis(methyl methoxyisobutyl phosphino)ethane, (3) FURPE, 1,2-bis(methyl tetrahydrofuran phosphino)ethane, and (4) PYRPE, 1,2-bis(methyl tetrahydropyran phosphino)ethane. These ligands have been reacted with 99mTc and the resulting complexes evaluated for myocardial imaging properties. 99mTc(MMPE)3+ exhibited the most favorable myocardial imaging characteristics in animal models. Results indicate that pendent ether moieties can improve the myocardial imaging properties of cationic technetium complexes.

A novel chromium(0)-promoted four-component cycloaddition reaction.

[formula: see text] Reaction of (eta 6-thiepin-1,1-dioxide)tricarbonylchromium(0) with excess terminal alkynes under photoactivation conditions affords novel pentacyclic adducts formally derived from a sequential [6 pi + 2 pi]/[6 pi + 2 pi]/[2 sigma + 2 pi] cycloaddition process.

Absolute configuration of (+)-alpha-dihydrotetrabenazine, an active metabolite of tetrabenazine.

Chiral column liquid chromatography and enantiospecific enzymatic hydrolysis were utilized to separate the enantiomers of alpha- and beta-dihydrotetrabenazine and alpha-9-O-desmethyldihydrotetrabenazine, three benzo[a]quinolizines derived from the amine-depleting drug tetrabenazine. An X-ray crystal structure analysis of (-)-alpha-9-O-desmethyldihydrotetrabenazine gave an absolute structure of that compound as the 2S, 3S, 11bS isomer. Therefore, (-)-alpha-dihydrotetrabenazine also has the 2S, 3S, 11bS absolute configuration. (+)-alpha-Dihydrotetrabenazine, the single biologically active isomer from the metabolic reduction of tetrabenazine, thus has the absolute configuration of 2R, 3R, 11bR. For further in vitro and in vivo studies of the vesicular monoamine transporter, it is now possible to use the single enantiomer of radiolabeled alpha-dihydrotetrabenazine.

The placebo effect.

The placebo effect will have a growing importance in the field of nuclear medicine as the potentials for palliative therapy with internal sources are realized. It is important for nuclear medicine physicians and their colleagues to be familiar with the role of placebo responses in clinical trials, especially when such trials involve the subjective assessment of pain. A summary of the literature on the placebo effect in pain studies is presented in which traditional values for placebo responses are contrasted with more current thinking in the field. The few published double-blind studies of pain relief after treatment with radiotherapeutic agents are summarized specifically with respect to their cited placebo response.

Crystal structure, receptor binding, and gene regulation of 2- and 4-nitroestradiols.

Crystal structures of 2-nitroestradiol and 4-nitroestradiol showed two different molecular conformations for each compound. The crystal structure of 4-nitroestradiol, as well as that of 4-nitroestrone-3-methyl ether, displayed a nitro group in which the oxygens were perpendicular to the aromatic ring and were this nonconjugating. On the other hand, the nitro-oxygens in 2-nitroestradiol were periplanar, with the aromatic ring permitting conjugating. This latter structure bound to estrogen receptor with 1/1000th the affinity of estradiol and was inefficient in gene stimulation. 4-Nitroestradiol possessed a relative binding affinity 40-fold greater than that of the 2-nitro derivative and actively induced responsive genes at a concentration of 10(-8) M. Whereas binding affinity can be explained primarily by polar groups and skeletal structure, gene induction may be linked to electronic induction in ring A that causes a requisite electronegative isopotential around the molecule. This electronegative characteristic also produces conformational changes in the alicyclic backbone of the estrogen, specially ring B, which could interfere with the molecular fit of the nitroestradiols with estrogen receptor.

Cationic [99mTcIII(DIARS)2(SR)2]+ complexes as potential myocardial perfusion imaging agents (DIARS = o-phenylenebis(dimethylarsine);SR- = thiolate).

Reduction-substitution reactions on [99mTcO4]- with both o-phenylenebis(dimethylarsine) (DIARS) and various thiols produce a series of monocationic [99Tc(DIARS)2(SR)2]+ complexes. Addition of [99gTcO4]- to the above reaction mixtures allows the characterization of the "carrier-added" complexes by means of reverse-phase high-performance liquid chromatography with radiometric and optical detection systems. The identity of the [99mTc(DIARS)2(SR)2]+ complexes is confirmed by fast atom bombardment mass spectroscopy; equivalence of the [99gTc(DIARS)2-(SR)2]+ and [99mTc(DIARS)2(SR)2]+ species is demonstrated by identical HPLC retention times. All the [99mTc(DIARS)2(SR)2]+ complexes tested accumulate in the myocardium of Sprague-Dawley rats with an average uptake of 1.5-2.0% of injected dose/g at 30 min. Thus, as designed, these nonreducible Tc(III) complexes do not exhibit the rapid myocardial washout observed for reducible Tc(III) complexes. These [99mTc(DIARS)2(SR)2]+ complexes also exhibit an initially high liver uptake, but the presence of ether groups within the thiolate ligands causes this liver uptake to decrease over time without affecting the heart uptake, thereby improving the heart/liver ratio.

Skeletal conformations and receptor binding of some 9,11-modified estradiols.

The effect of the modification of the 9-11 positions on the skeletal conformation of estradiol (E2) has been analyzed by X-ray crystallography and MM2 molecular mechanics. The 11 beta-hydroxyl and 11-keto analogs of E2 maintained ring conformations which were similar to the natural hormone (E2). Introduction of a double bond at position 9-11 induced a flattening of the entire steroid molecule. An 11 alpha-hydroxyl group brought about significant changes in the alicyclic rings of E2. 9 beta-Estradiol and 11-keto-9 beta-estradiol formed ring conformations which were significantly bent from E2 (below the plane of the A-ring). Examination of the affinity of these C-ring analogs of E2 for the human estrogen receptor has shown extreme variations. A hydroxyl group placed either alpha or beta at the 11-position yielded ligands with vastly different and reduced affinities for the receptor. The low affinity of 11 alpha-hydroxyestradiol (1/300th of E2) may be due to the drastic structural change induced in the alicyclic portion of the molecule, as well as, to the steric or electrostatic effects of the alpha-hydroxyl group upon the receptor protein. An 11 beta-hydroxyl group diminished the receptor binding to 1/60th that of E2 without alicyclic ring distortions, whereas a 9-11 unsaturation reduced the binding to 1/5th although this steroid displayed a flattening of rings B, C, and D. The 11-keto function, which had little effect on the conformation of the estrogen nucleus, reduced the affinity of this ligand to 1/1000th that of E2. The negative bend at the C-ring of 11-keto-9 beta-estradiol and 9 beta-estradiol prevented these ligands from binding receptor. Some of the observed receptor interactions were related to structural alterations in the estrogen ring system induced by modifications on the 9-11 region.

Binding, X-ray and NMR studies of the three A-ring isomers of natural estradiol.

The effect of the position of the phenolic hydroxyl on the conformations of the three A-ring isomers of estradiol, namely, estra-1,3,5(10)-trien-1,17 beta-diol (10), estra-1,3,5(10)-trien-2,17 beta-diol (3), and estra-1,3,5(10)-trien-4,17 beta-diol (6), has been analyzed by X-ray crystallography. The results of these analyses were correlated with the absorptions of the angular methyl groups in the [1H]NMR spectra of these isomers and natural estradiol (E2). It was observed that the changes in chemical shift of protons at C18 corresponded to skeletal modifications in the steroid structure which changed the anisotropic effect of the hydroxyl group at C17. Examination of the affinity of these A-ring isomers of E2 for the estrogen receptor has shown the 2-hydroxylated isomer 3 to retain 1/5th the affinity of E2 for its binding protein. The 1- and 4-hydroxylated derivatives (10 and 6, respectively) bound to a much lesser extent. The receptor affinities of these estrogen analogues may be related to the angle between the 18-methyl and the 17 beta-hydroxyl groups (or the dihedral angle between the planar A-ring and the angular C18 methyl) as well as the position of the A-ring hydroxyl group.